CA2346670A1 - Composition for the parenteral administration of active compounds - Google Patents
Composition for the parenteral administration of active compounds Download PDFInfo
- Publication number
- CA2346670A1 CA2346670A1 CA002346670A CA2346670A CA2346670A1 CA 2346670 A1 CA2346670 A1 CA 2346670A1 CA 002346670 A CA002346670 A CA 002346670A CA 2346670 A CA2346670 A CA 2346670A CA 2346670 A1 CA2346670 A1 CA 2346670A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- active compound
- microparticles
- water
- suspension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1998147593 DE19847593A1 (de) | 1998-10-15 | 1998-10-15 | Zusammensetzung für die parenterale Applikation von Wirkstoffen |
DE19847593.4 | 1998-10-15 | ||
PCT/EP1999/007300 WO2000021505A2 (de) | 1998-10-15 | 1999-10-02 | Zusammensetzung für die parenterale applikation von wirkstoffen |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2346670A1 true CA2346670A1 (en) | 2000-04-20 |
Family
ID=7884587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002346670A Abandoned CA2346670A1 (en) | 1998-10-15 | 1999-10-02 | Composition for the parenteral administration of active compounds |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1124538A2 (no) |
JP (1) | JP2002527376A (no) |
AU (1) | AU6198999A (no) |
CA (1) | CA2346670A1 (no) |
DE (1) | DE19847593A1 (no) |
NO (1) | NO20011670L (no) |
PL (1) | PL347770A1 (no) |
WO (1) | WO2000021505A2 (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10022095B4 (de) * | 2000-05-08 | 2005-07-14 | Südzucker AG Mannheim/Ochsenfurt | Gel aus einem Poly-α-1,4-Glucan und Stärke |
DE10119522A1 (de) * | 2001-04-20 | 2002-12-05 | Innovacell Biotechnologie Gmbh | Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel |
SI1711058T1 (sl) | 2004-01-23 | 2022-02-28 | Eden Research Plc, | Postopki za uničevanje nematod, ki obsega uporabo terpenske komponente |
CN1997446B (zh) | 2004-05-20 | 2012-01-04 | 伊顿研究有限公司 | 含有包封萜成分的中空葡聚糖颗粒或细胞壁颗粒的组合物、其制备和使用方法 |
WO2008106571A2 (en) | 2007-02-28 | 2008-09-04 | Abbott Laboratories | Sustained release parenteral formulations of buprenorphine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2646879A1 (de) * | 1975-10-21 | 1977-05-05 | Takeda Chemical Industries Ltd | Matrix aus einem in wasser unloeslichen beta-1,3-glucangel und verfahren zu ihrer herstellung |
DE3045135A1 (de) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
ES2287935T3 (es) * | 1994-05-18 | 2007-12-16 | Bayer Bioscience Gmbh | Secuencias de adn codificantes de enzimas capaces de facilitar la sintesis de a-1,4 glucanos lineales en plantas, hongos y microorganismos. |
DE19737481A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Ag | Sphärische lineare Polysaccharide enthaltende Mikropartikel |
DE59909854D1 (de) * | 1998-04-09 | 2004-08-05 | Celanese Ventures Gmbh | Partikulärer wirkstoffträger für die pulmonale applikation |
DE19839216C1 (de) * | 1998-08-28 | 2000-01-20 | Aventis Res & Tech Gmbh & Co | Verfahren zur Herstellung von sphärischen Mikropartikeln, die ganz oder teilweise aus mindestens einem wasserunlöslichen Verzweigungen enthaltenden Polyglucan bestehen, sowie mit diesem Verfahren erhältliche Mikropartikel und die Verwendung |
-
1998
- 1998-10-15 DE DE1998147593 patent/DE19847593A1/de not_active Withdrawn
-
1999
- 1999-10-02 AU AU61989/99A patent/AU6198999A/en not_active Abandoned
- 1999-10-02 WO PCT/EP1999/007300 patent/WO2000021505A2/de not_active Application Discontinuation
- 1999-10-02 JP JP2000575481A patent/JP2002527376A/ja active Pending
- 1999-10-02 CA CA002346670A patent/CA2346670A1/en not_active Abandoned
- 1999-10-02 PL PL34777099A patent/PL347770A1/xx unknown
- 1999-10-02 EP EP99948917A patent/EP1124538A2/de not_active Withdrawn
-
2001
- 2001-04-03 NO NO20011670A patent/NO20011670L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU6198999A (en) | 2000-05-01 |
PL347770A1 (en) | 2002-04-22 |
WO2000021505A2 (de) | 2000-04-20 |
EP1124538A2 (de) | 2001-08-22 |
JP2002527376A (ja) | 2002-08-27 |
NO20011670L (no) | 2001-06-12 |
DE19847593A1 (de) | 2000-04-20 |
WO2000021505A3 (de) | 2000-09-21 |
NO20011670D0 (no) | 2001-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mitra et al. | Chitosan microspheres in novel drug delivery systems | |
Varshosaz et al. | Nasal delivery of insulin using chitosan microspheres | |
EP1906928B1 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
Agnihotri et al. | Recent advances on chitosan-based micro-and nanoparticles in drug delivery | |
JP4537057B2 (ja) | 脂質化グリコサミノグリカン粒子ならびに診断及び処置のための薬物及び遺伝子送達におけるその使用 | |
JP3094074B2 (ja) | 多糖ゲル組成物 | |
TWI314461B (en) | Amphiphilic block copolymers and nano particles comprising the same | |
WO1984000294A1 (en) | A crystallised carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof | |
CN101374530A (zh) | 壳聚糖和肝素纳米微粒 | |
Gupta et al. | Optimization of process variables for the preparation of chitosan-alginate nanoparticles | |
CA2583341A1 (en) | Method of formation of the shape-retentive aggregates of gel particles and their uses | |
Pal et al. | Chitosan based delivery systems on a length scale: Nano to macro | |
EP1371364B1 (en) | Proces for the preparation of a controlled release system | |
Mohammadpour et al. | Preparing and characterizing chitosan nanoparticles containing hemiscorpius lepturus scorpion venom as an antigen delivery system | |
Lee et al. | Stabilization of protein encapsulated in poly (lactide-co-glycolide) microspheres by novel viscous S/W/O/W method | |
Chauhan et al. | Pharmaceutical polymers | |
US8017152B2 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
Priya Dasan et al. | Polymer blend microspheres for controlled drug release: the techniques for preparation and characterization: a review article | |
AU2003205106A8 (en) | Pace-a microspheres for delivery of antigens | |
CA2346670A1 (en) | Composition for the parenteral administration of active compounds | |
Portilla‐Arias et al. | Biodegradable Nanoparticles of Partially Methylated Fungal Poly (β‐l‐malic acid) as a Novel Protein Delivery Carrier | |
Chouhan et al. | An updated review on nanoparticle based approach for nanogel drug delivery system | |
Sahu et al. | Design and evaluation of a nanoparticulate system prepared by biodegradable polymers for oral administration of protein drugs | |
CN115337272B (zh) | 一种天然多糖基化学-物理双交联水凝胶微粒及其制备与应用 | |
Manna et al. | Interpenetrating polymer network in microparticulate systems: drug delivery and biomedical application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |